Abstract:Objective: Considering the essential role of KRAS mutation in NSCLC and the limited experience of PET radiomic features in KRAS mutation, a prediction model was built in our current analysis. Our model aims to evaluate the status of KRAS mutants in lung adenocarcinoma by combining PET radiomics and machine learning. Method: Patients were retrospectively selected from our database and screened from the NSCLC radiogenomic dataset from TCIA. The dataset was randomly divided into three subgroups. Two open-source software programs, 3D Slicer and Python, were used to segment lung tumours and extract radiomic features from 18F-FDG-PET images. Feature selection was performed by the Mann-Whitney U test, Spearman's rank correlation coefficient, and RFE. Logistic regression was used to build the prediction models. AUCs from ROCs were used to compare the predictive abilities of the models. Calibration plots were obtained to examine the agreements of observed and predictive values in the validation and testing groups. DCA curves were performed to check the clinical impact of the best model. Finally, a nomogram was obtained to present the selected model. Results: One hundred and nineteen patients with lung adenocarcinoma were included in our study. The whole group was divided into three datasets: a training set (n = 96), a validation set (n = 11), and a testing set (n = 12). In total, 1781 radiomic features were extracted from PET images. One hundred sixty-three predictive models were established according to each original feature group and their combinations. After model comparison and selection, one model, including wHLH_fo_IR, wHLH_glrlm_SRHGLE, wHLH_glszm_SAHGLE, and smoking habits, was validated with the highest predictive value. The model obtained AUCs of 0.731 (95% CI: 0.619~0.843), 0.750 (95% CI: 0.248~1.000), and 0.750 (95% CI: 0.448~1.000) in the training set, the validation set and the testing set, respectively. Results from calibration plots in validation and testing groups indicated that there was no departure between observed and predictive values in the two datasets (p = 0.377 and 0.861, respectively). Conclusions: Our model combining 18F-FDG-PET radiomics and machine learning indicated a good predictive ability of KRAS status in lung adenocarcinoma. It may be a helpful non-invasive method to screen the KRAS mutation status of heterogenous lung adenocarcinoma before selected biopsy sampling.

Development and Validation of Radiomics Signatures to Predict KRAS Mutation Status Based on Triphasic Enhanced Computed Tomography in Patients with Colorectal Cancer

CT Delta-Radiomics for Identification of Advanced EGFR-Mutated Lung Adenocarcinoma Sensitive to Therapies Targeting EGFR Pathway

Construction of prediction model for KRAS mutation status of colorectal cancer based on CT radiomics

Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?

Development and Validation of a MRI-based Radiomics Signature for Prediction of KRAS Mutation in Rectal Cancer

KRAS mutation status between left- and right-sided colorectal cancer: are there any differences in computed tomography?

Predicting Kirsten Rat Sarcoma Virus Gene Mutation Status in Patients With Colorectal Cancer by Radiomics Models Based on Multiphasic CT

MRI Radiomics Signature As a Potential Biomarker to Predict Different KRAS Status in Colorectal Cancer Patients and Tumor Cells

MRI Radiomics Signature as a Potential Biomarker for Predicting KRAS Status in Locally Advanced Rectal Cancer Patients

Deep Learning Features Improve the Performance of a Radiomics Signature for Predicting KRAS Status in Patients with Colorectal Cancer

Predicting Microsatellite Instability Status in Colorectal Cancer Based on Triphasic Enhanced Computed Tomography Radiomics Signatures: A Multicenter Study

Feasibility of MRI Radiomics for Predicting KRAS Mutation in Rectal Cancer

CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer

Current status and quality of radiomic studies for predicting KRAS mutations in Colorectal cancer patients: a systematic review and meta‐analysis

KRAS Status Predicted by Pretreatment MRI Radiomics Was Associated with Lung Metastasis in Locally Advanced Rectal Cancer Patients.

Ability of 18F-FDG Positron Emission Tomography Radiomics and Machine Learning in Predicting KRAS Mutation Status in Therapy-Naive Lung Adenocarcinoma

Noninvasive KRAS mutation estimation in colorectal cancer using a deep learning method based on CT imaging

Development of a dual-energy spectral CT based nomogram for the preoperative discrimination of mutated and wild-type KRAS in patients with colorectal cancer.

Value of 18F-FDG PET/CT radiomics for predicting KRAS gene mutations in non-small cell lung cancer

Prediction of KRAS, NRAS and BRAF status in colorectal cancer patients with liver metastasis using a deep artificial neural network based on radiomics and semantic features.

Noninvasive KRAS mutation estimation in colorectal cancer using a deep learning method based on routine CT imaging